Alzheimer’s is a form of dementia that can cause problems with memory, thinking and behavior, according to the Alzheimer’s Association. It is the most common form of dementia that gets worse over time. Nearly 6 million Americans presently live with Alzheimer’s— and there’s no cure for it. The disease is caused by protein buildups […]
NeuroVision
J&J gets in on $15m Series C for NeuroVision Imaging
NeuroVision Imaging said today it raised $15 million in a Series C round joined by Johnson & Johnson‘s (NYSE:JNJ) Innovation arm, with funds slated to support validation and approval of the company’s eye imaging system. The round was led by Wildcat Capital Management and joined by J&J Innovation, Nikon-SBI Innovation Fund, Whittier Ventures and VSP […]
New retinal imaging tech promises to help diagnose Alzheimers
New technology, developed by NeuroVision Imaging and Cedars-Sinai, is exploring the use of noninvasive eye imaging to detect Alzheimers disease, scanning the retina to identify protein deposits associated with the disorder. The system is designed to look for neurotoxic beta-amyloid protein deposits, which are also found in the brain in Alzheimers patients. Normally, such deposits […]
7 medtech stories we missed this week: March 3, 2017
Several clinical study results were published this week, while other companies reached distribution deals. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber […]